NO922603D0 - Nye benzomorfoner og deres anvendelse som legemiddel - Google Patents

Nye benzomorfoner og deres anvendelse som legemiddel

Info

Publication number
NO922603D0
NO922603D0 NO922603A NO922603A NO922603D0 NO 922603 D0 NO922603 D0 NO 922603D0 NO 922603 A NO922603 A NO 922603A NO 922603 A NO922603 A NO 922603A NO 922603 D0 NO922603 D0 NO 922603D0
Authority
NO
Norway
Prior art keywords
alkyl
new
benzomorphones
medicine
acyl
Prior art date
Application number
NO922603A
Other languages
English (en)
Other versions
NO922603L (no
NO178263B (no
NO178263C (no
Inventor
Adrian Carter
Helmut Ensinger
Matthias Grauert
Franz Joseph Kuhn
Herbert Merz
Enzio Mueller
Werner Stransky
Ilse Streller
Original Assignee
Boehringer Ingelheim Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Kg filed Critical Boehringer Ingelheim Kg
Publication of NO922603D0 publication Critical patent/NO922603D0/no
Publication of NO922603L publication Critical patent/NO922603L/no
Publication of NO178263B publication Critical patent/NO178263B/no
Publication of NO178263C publication Critical patent/NO178263C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/22—Bridged ring systems
    • C07D221/26—Benzomorphans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO922603A 1991-07-02 1992-07-01 Nye benzomorfaner og deres anvendelse som legemiddel NO178263C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4121821A DE4121821A1 (de) 1991-07-02 1991-07-02 Neue benzomorphane und ihre verwendung als arzneimittel

Publications (4)

Publication Number Publication Date
NO922603D0 true NO922603D0 (no) 1992-07-01
NO922603L NO922603L (no) 1993-01-04
NO178263B NO178263B (no) 1995-11-13
NO178263C NO178263C (no) 1996-02-21

Family

ID=6435223

Family Applications (1)

Application Number Title Priority Date Filing Date
NO922603A NO178263C (no) 1991-07-02 1992-07-01 Nye benzomorfaner og deres anvendelse som legemiddel

Country Status (24)

Country Link
EP (1) EP0521422B1 (no)
JP (1) JP3324785B2 (no)
KR (1) KR100251256B1 (no)
AT (1) ATE137749T1 (no)
AU (1) AU657330B2 (no)
CA (1) CA2072814C (no)
CZ (1) CZ286949B6 (no)
DE (2) DE4121821A1 (no)
DK (1) DK0521422T3 (no)
ES (1) ES2086585T3 (no)
FI (1) FI105913B (no)
GR (1) GR3020124T3 (no)
HK (1) HK1003111A1 (no)
HU (1) HU220873B1 (no)
IE (1) IE74400B1 (no)
IL (1) IL102361A (no)
MX (1) MX9203845A (no)
NO (1) NO178263C (no)
NZ (1) NZ243388A (no)
PH (1) PH31430A (no)
SG (1) SG43001A1 (no)
SK (1) SK280776B6 (no)
TW (1) TW214547B (no)
ZA (1) ZA924883B (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19528472A1 (de) * 1995-08-03 1997-02-06 Boehringer Ingelheim Kg Neues Verfahren zur Herstellung von Norbenzomorphan einer Zwischenstufe bei Herstellung von pharmazeutisch wertvollen Benzomorphanderivaten, insbesondere von (-)-(1R,5S,S"R)-3'-Hydroxy-2-(2-methoxypropyl-)-5,9,9-trimethyl-6,7 benzomorphan
DE19740110A1 (de) * 1997-09-12 1999-03-18 Boehringer Ingelheim Pharma Substituierte 1,2,3,4,5,6-Hexahydro-2,6-methano-3-benzazocin-10-ole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
JPH1196519A (ja) * 1997-09-17 1999-04-09 Alps Electric Co Ltd スピンバルブ型薄膜素子およびその製造方法
US6136980A (en) * 1998-05-01 2000-10-24 Boehringer Ingelheim Kg Method of preparing norbenzomorphane as an intermediate in the preparation of pharmaceutically useful benzomorphane derivatives, in particular (-)-(1R,5S,2"R)-3'-hydroxy-2-(2-methoxypropyl)-5,9,9-trimethyl-6,7-benzo morphane
DE19826365A1 (de) * 1998-06-12 1999-12-16 Gruenenthal Gmbh Verwendung von Benzomorphanderivaten als Analgetikum
US6355652B1 (en) 1999-11-27 2002-03-12 Boehringer Ingelheim Pharma Kg Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines and their use as pharmaceutical compositions
DE19957156A1 (de) * 1999-11-27 2001-05-31 Boehringer Ingelheim Pharma Substituierte 1,2,3,4,5,6-Hexahydro-2,6-methano-3-benzazocine und ihre Verwendung als Arzneimittel
DE10204276A1 (de) * 2002-02-02 2003-08-07 Boehringer Ingelheim Pharma N-Allyloxyethyl-1,2,3,4,5,6-Hexahydro-2,6-methano-3-benzazocine und ihre Verwendung als Arzneimittel
MXPA04011327A (es) 2002-05-17 2005-08-15 Jenken Biosciences Inc Opioides y compuestos similares a opioides y usos de los mismos.
US7501433B2 (en) 2002-05-17 2009-03-10 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
US7923454B2 (en) 2002-05-17 2011-04-12 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
US8017622B2 (en) 2003-05-16 2011-09-13 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
US8859580B2 (en) * 2007-11-16 2014-10-14 Boehringer Ingelheim International Gmbh Aryl- and heteroarylcarbonyl derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use
WO2015097545A1 (en) 2013-12-26 2015-07-02 Purdue Pharma L.P. Opioid receptor modulating oxabicyclo[2.2.2]octane morphinans

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7804509A (nl) * 1978-04-26 1979-10-30 Acf Chemiefarma Nv Nieuwe 6,7-benzomorfanderivaten en zuuradditiezouten daarvan.
DE2828039A1 (de) * 1978-06-26 1980-01-10 Boehringer Sohn Ingelheim 2-(2-alkoxyethyl)-2'-hydroxy-6,7-benzomorphane deren saeureadditionssalze diese enthaltende arzneimittel und verfahren zu deren herstellung
NL7907800A (nl) * 1979-10-23 1981-04-27 Acf Chemiefarma Nv Nieuwe 6,7-benzomorfanderivaten en zuuradditiezouten daarvan, farmaceutische preparaten die een dergelijke verbinding bevatten, alsmede werkwijze voor het bereiden van deze verbindingen en de farmaceutische preparaten.

Also Published As

Publication number Publication date
ES2086585T3 (es) 1996-07-01
SK280776B6 (sk) 2000-07-11
NO922603L (no) 1993-01-04
CA2072814C (en) 2003-09-23
AU657330B2 (en) 1995-03-09
JPH05201987A (ja) 1993-08-10
ATE137749T1 (de) 1996-05-15
FI923050A0 (fi) 1992-07-01
EP0521422A1 (de) 1993-01-07
IL102361A (en) 1997-02-18
DK0521422T3 (da) 1996-06-10
KR930002321A (ko) 1993-02-22
CZ286949B6 (cs) 2000-08-16
JP3324785B2 (ja) 2002-09-17
HU9202199D0 (en) 1992-10-28
CA2072814A1 (en) 1993-01-03
SG43001A1 (en) 1997-10-17
FI105913B (fi) 2000-10-31
IE74400B1 (en) 1997-07-30
NZ243388A (en) 1994-11-25
EP0521422B1 (de) 1996-05-08
HK1003111A1 (en) 1998-10-09
HUT66410A (en) 1994-11-28
CZ207592A3 (en) 1993-08-11
MX9203845A (es) 1993-01-01
DE59206212D1 (de) 1996-06-13
SK207592A3 (en) 1997-01-08
KR100251256B1 (ko) 2000-05-01
IL102361A0 (en) 1993-01-14
ZA924883B (en) 1993-02-24
PH31430A (en) 1998-11-03
AU1868692A (en) 1993-01-07
DE4121821A1 (de) 1993-01-14
NO178263B (no) 1995-11-13
FI923050A (fi) 1993-01-03
NO178263C (no) 1996-02-21
GR3020124T3 (en) 1996-08-31
TW214547B (no) 1993-10-11
IE922144A1 (en) 1993-01-13
HU220873B1 (en) 2002-06-29

Similar Documents

Publication Publication Date Title
NO922603L (no) Nye benzomorfoner og deres anvendelse som legemiddel
HUP0003731A2 (hu) 4-Bróm- vagy 4-jód-fenil-amino-benzhidroxámsav-származékok és ilyen vegyületek MEK gátlóként való alkalmazása
DK0920421T3 (da) Isoxazolinderivater anvendelige som antimikrobielle midler
ES2180633T3 (es) Uso de derivados de pteridina como inhibidores de la no-sintasa.
NO912940L (no) Immunundertrykkende middel og fremgangsmaate for fremstilling av samme.
DK0671156T3 (da) Kosmetiske eller farmaceutiske præparater indeholdende liposomer
DK0509398T3 (da) Quinoxaliner, fremgangsmåder til deres fremstilling samt deres anvendelse
YU12992A (sh) 2-amino-1,2,3,4,-tetrahidronaftaleni supstituisani u prstenu
ES2177656T3 (es) Derivados de antraciclinona y su utilizacion en el tratamiento de la amiloidosis.
LV11817A (lv) Arilalkil-amini un -amidi ar pretkrampju un neiroprotektivam ipasibam
TW333532B (en) Benzopyrans
DK0873993T3 (da) Hidtil ukendte heterocykliske forbindelser, fremgangsmåde til deres fremstilling og sammensætninger indeholdende dem
SE0004480D0 (sv) Novel compounds

Legal Events

Date Code Title Description
MK1K Patent expired